The invention discloses a function of HOXD-AS1 in diagnosis and treatment of esophageal
squamous carcinoma and relates to discovery, detection and application of long-chain noncoding
RNA. According to the sequences of the long-chain noncoding
RNA, a specific real-time quantitative PCR primer is designed and synthesized; a real-time quantitative PCR preparation is utilized to detect the expression level of the long-chain noncoding
RNA in a
clinical case specimen of the esophageal
squamous carcinoma, and results show that the expression of the long-chain noncoding RNA in the esophageal
squamous carcinoma is remarkably up-regulated and the expression level of the long-chain noncoding RNA is highly associated with both clinical stages and
pathological N stages of an esophageal squamous
carcinoma patient. The
specific detection sequences disclosed by the invention are expected to be used for preparing the preparation for auxiliary diagnosis,
curative effect prediction or prognosis judgment of the esophageal squamous
carcinoma. In addition, two siRNA sequences for specifically knocking down the expression of the long-chain noncoding RNA are designed and synthesized; an experiment proves that after the expression level of the long-chain noncoding RNA is specifically knocked down in a human esophageal squamous
carcinoma cell strain, the quantity of migrated
tumor cells is remarkably reduced; therefore the siRNA sequences disclosed by the invention is also expected to be used as a
molecular targeting treatment tool for inhibiting the
cell migration rate of the esophageal squamous carcinoma.